Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00259766
Other study ID # D5890L00001
Secondary ID SHARE
Status Completed
Phase Phase 3
First received November 25, 2005
Last updated January 21, 2011
Start date April 2004
Est. completion date May 2007

Study information

Verified date January 2011
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Sweden: Medical Products Agency
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare health-related costs and asthma control in ordinary clinical practice during 12 months for Symbicort® given as a low maintenance dose plus as needed compared to a free combination of Pulmicortâ and Oxis® plus Bricanyl® as needed, and Symbicort fixed dosing plus Bricanyl as needed in asthmatic patients not adequately controlled on inhaled glucocorticosteroids alone.


Recruitment information / eligibility

Status Completed
Enrollment 1970
Est. completion date May 2007
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 12 Years and older
Eligibility Inclusion Criteria:

- Signed informed consent,

- asthma,

- previously treated with glucocorticosteroids and B2-agonist

Exclusion Criteria:

- History of smoking, pregnancy, any significant disease or disorder which may put the patient at risk because of study participation

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Budesonide

Formoterol

Terbutaline


Locations

Country Name City State
Sweden Research Site Akersberga
Sweden Research Site Alingsas
Sweden Research Site Ånge
Sweden Research Site Angelholm
Sweden Research Site Angered
Sweden Research Site Arlov
Sweden Research Site Årsta
Sweden Research Site Arvidsjaur
Sweden Research Site Arvika
Sweden Research Site Åstorp
Sweden Research Site Atvidaberg
Sweden Research Site Bandhagen
Sweden Research Site Boden
Sweden Research Site Borensberg
Sweden Research Site Bro
Sweden Research Site Brunflo
Sweden Research Site Eskilstuna
Sweden Research Site Falun
Sweden Research Site Filipstad
Sweden Research Site Fränsta
Sweden Research Site Gagnef
Sweden Research Site Gärsnäs
Sweden Research Site Göteborg
Sweden Research Site Grängesberg
Sweden Research Site Gullspång
Sweden Research Site Haby
Sweden Research Site Halmstad
Sweden Research Site Helsingborg
Sweden Research Site Hisingsbacka
Sweden Research Site Hofors
Sweden Research Site Höganäs
Sweden Research Site Hollviken
Sweden Research Site Huddinge
Sweden Research Site Iggesund
Sweden Research Site Jarfalla
Sweden Research Site Kalmar
Sweden Research site Karlskoga
Sweden Research Site Karlstad
Sweden Research Site Katrineholm
Sweden Research Site Kil
Sweden Research Site Kinna
Sweden Research Site Klippan
Sweden Research Site Kolmården
Sweden Research Site Kristinehamn
Sweden Research Site Kungalv
Sweden Research Site Kungsbacka
Sweden Research Site Kungsör
Sweden Research Site Landskrona
Sweden Research Site Laxå
Sweden Research Site Leksand
Sweden Research Site Lerum
Sweden Research Site Lidingö
Sweden Research Site Likenäs
Sweden Research Site Limhamn
Sweden Research Site Lindome
Sweden Research Site Linköping
Sweden Research Site Ljungskile
Sweden Research Site Ludvika
Sweden Research Site Luleå
Sweden Research Site Lund
Sweden Research Site Malmo
Sweden Research Site Mariefred
Sweden Research Site Molndal
Sweden Research site Molnlycke
Sweden Research Site Nacka
Sweden Research Site Norrkoping
Sweden Research Site Norrtälje
Sweden Research Site Nyköping
Sweden Research site Ödeshög
Sweden Research Site Örebro
Sweden Research site Osby
Sweden Research Site Påarp
Sweden Research Site Partille
Sweden Reseearch Site Perstorp
Sweden Research Site Saltsjo-Bo
Sweden Research Site Sandviken
Sweden Research Site Sjobo
Sweden Research Site Sjuntorp
Sweden Research Site Söderköping
Sweden Research site Sollentuna
Sweden Research Site Solna
Sweden Research site Stenstorp
Sweden Research Site Stenungsund
Sweden Research Site Stockholm
Sweden Research Site Storfors
Sweden Research Site Stugun
Sweden Research Site Sundbyberg
Sweden Research Site Sundsvall
Sweden Research Site Sunne
Sweden Research Site Täby
Sweden Research Site Trollhättan
Sweden Research Site Trosa
Sweden Research Site Tyresö
Sweden Research Site Uddevalla
Sweden Research site Ulricehamn
Sweden Research Site Umeå
Sweden Research Site Uppsala
Sweden Research Site Vallentuna
Sweden Research Site Vännäs
Sweden Research Site Varberg
Sweden Research Site Varnamo
Sweden Research site Väsby
Sweden Research Site Västerås
Sweden Research Site Västervik
Sweden Research site Västra Frölunda
Sweden Research Site Vellinge
Sweden Research Site Ystad
Sweden Research Site Ytterby

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Asthma-related health-care utilization as measured by total amount of asthma medication purchased and number of contacts with health-care facilities
Secondary Number of days patients or assistant persons are absent from work due to patient's asthma
Secondary Number of exacerbations and treatment failures
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device